157 related articles for article (PubMed ID: 33277302)
1. A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes.
Palisaitis E; El Fathi A; von Oettingen JE; Haidar A; Legault L
Diabetes Care; 2021 Feb; 44(2):604-606. PubMed ID: 33277302
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
3. Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System.
Samadi S; Rashid M; Turksoy K; Feng J; Hajizadeh I; Hobbs N; Lazaro C; Sevil M; Littlejohn E; Cinar A
Diabetes Technol Ther; 2018 Mar; 20(3):235-246. PubMed ID: 29406789
[TBL] [Abstract][Full Text] [Related]
4. Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.
Cherñavvsky DR; DeBoer MD; Keith-Hynes P; Mize B; McElwee M; Demartini S; Dunsmore SF; Wakeman C; Kovatchev BP; Breton MD
Pediatr Diabetes; 2016 Feb; 17(1):28-35. PubMed ID: 25348683
[TBL] [Abstract][Full Text] [Related]
5. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
Pinsker JE; Lee JB; Dassau E; Seborg DE; Bradley PK; Gondhalekar R; Bevier WC; Huyett L; Zisser HC; Doyle FJ
Diabetes Care; 2016 Jul; 39(7):1135-42. PubMed ID: 27289127
[TBL] [Abstract][Full Text] [Related]
6. A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Haidar A; Tsoukas MA; Bernier-Twardy S; Yale JF; Rutkowski J; Bossy A; Pytka E; El Fathi A; Strauss N; Legault L
Diabetes Care; 2020 Mar; 43(3):597-606. PubMed ID: 31974099
[TBL] [Abstract][Full Text] [Related]
7. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
Forlenza GP; Cameron FM; Ly TT; Lam D; Howsmon DP; Baysal N; Kulina G; Messer L; Clinton P; Levister C; Patek SD; Levy CJ; Wadwa RP; Maahs DM; Bequette BW; Buckingham BA
Diabetes Technol Ther; 2018 May; 20(5):335-343. PubMed ID: 29658779
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
9. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
[TBL] [Abstract][Full Text] [Related]
10. Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
Song L; Liu C; Yang W; Zhang J; Kong X; Zhang B; Chen X; Wang N; Shen D; Li Z; Jin X; Shuai Y; Wang Y
Comput Methods Programs Biomed; 2020 Jul; 191():105416. PubMed ID: 32146213
[TBL] [Abstract][Full Text] [Related]
11. Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Maltoni G; Allen JM; Nodale M; Kumareswaran K; Leelarathna L; Thabit H; Caldwell K; Wilinska ME; Calhoun P; Kollman C; Dunger DB; Hovorka R
Diabetes Obes Metab; 2014 Nov; 16(11):1174-8. PubMed ID: 24909206
[TBL] [Abstract][Full Text] [Related]
12. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.
Blauw H; Onvlee AJ; Klaassen M; van Bon AC; DeVries JH
Diabetes Care; 2021 Mar; 44(3):836-838. PubMed ID: 33397767
[TBL] [Abstract][Full Text] [Related]
13. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
[TBL] [Abstract][Full Text] [Related]
14. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
[TBL] [Abstract][Full Text] [Related]
15. Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement.
Fushimi E; Colmegna P; De Battista H; Garelli F; Sánchez-Peña R
J Diabetes Sci Technol; 2019 Nov; 13(6):1035-1043. PubMed ID: 31339059
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.
Gingras V; Rabasa-Lhoret R; Messier V; Ladouceur M; Legault L; Haidar A
Diabetes Metab; 2016 Feb; 42(1):47-54. PubMed ID: 26072052
[TBL] [Abstract][Full Text] [Related]
17. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
18. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
El-Khatib FH; Russell SJ; Magyar KL; Sinha M; McKeon K; Nathan DM; Damiano ER
J Clin Endocrinol Metab; 2014 May; 99(5):1701-11. PubMed ID: 24483160
[TBL] [Abstract][Full Text] [Related]
19. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.
Breton M; Farret A; Bruttomesso D; Anderson S; Magni L; Patek S; Dalla Man C; Place J; Demartini S; Del Favero S; Toffanin C; Hughes-Karvetski C; Dassau E; Zisser H; Doyle FJ; De Nicolao G; Avogaro A; Cobelli C; Renard E; Kovatchev B;
Diabetes; 2012 Sep; 61(9):2230-7. PubMed ID: 22688340
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach.
Jafar A; Fathi AE; Haidar A
Comput Methods Programs Biomed; 2021 Mar; 200():105936. PubMed ID: 33515844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
